DUBAI, United Arab Emirates, Feb. 08, 2022 (GLOBE NEWSWIRE) -- As per the Future Market Insights research, the drug screening market is forecasted to advance at a tremendous pace with a CAGR of 16% during the forecast period 2022-2032.
Drug Screening Market to reach US$ 5.3 Bn in 2021 to US$ 18 Bn by 2032 showing an immense improvement
| Attributes | Details |
| Drug Screening Market CAGR (2022 – 2032) | 16% |
| Drug Screening Market (2026) | US$ 11 Bn |
| Drug Screening Market Attraction | Imposition of strict laws about drug abuse to offer opportunities in North America. |
A crucial driver of the drug screening market is the overuse of prescribed drugs and the elevated use of narcotics. According to one of the recent World Drug Reports, drug and alcohol abuse and consumption are on the rise globally.
Drug abuse killed nearly 500,000 people, while drug use disorders resulted in the loss of 18 million years of a healthy life, primarily due to opioids. Similar increases in alcohol consumption have been observed, with the consequences being an increase in the incidence of impaired driving.
Request for Report Sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-14265
The rising consumption of illicit drugs and alcohol will accelerate the development of drug screening products and services on the road, fuelling the drug screening market growth.
Some countries, including South Africa, Colombia, Chile, Argentina, and Canada, consider workplace drug and alcohol testing to violate employee privacy. Such prohibitions in various countries may impede the adoption of drug screening devices etc., thereby limiting the overall market growth.
Several new products, devices, and services have also received regulatory approval and are being adopted by government agencies and corporate organizations and are expected to broaden drug screening market opportunities.
Companies in this market are expected to gain new opportunities as their business strategies shift toward oral swab drug tests and the development of the concept of fingerprint-based drug screening, thereby driving the demand for drug screening devices etc.,
Furthermore, New Psychoactive Substances (NPS) such as tryptamines, ketamine, piperazine, and phenethylamines can be considered emerging trends in the drug screening market. Owing to its low cost and dependability, urine samples are the most commonly used for testing, ramping up urine drug tests.
Influenced by factors as mentioned earlier and developments, the drug screening market is forecasted to touch US$ 11 Bn by 2026.
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-14265
Key Takeaways:
- By product type, the consumables segment is likely to dominate the market since they provide improved solutions to make testing accurate and quick, accelerating market growth.
- As it is a quicker and less invasive sample to collect at the roadside, the oral fluid sample segment is expected to account for a significant drug screening market share by sample type.
- By drug type, the cannabis/marijuana segment is forecasted to hold sway over the drug testing industry since marijuana or cannabis is the most commonly used illicit substance in critical markets.
- Drug testing laboratories are predicted to be at the forefront of the market by end-use, owing to their widespread acceptance and accurate result.
- The drug screening market size accounted for around US$ 5.3 Bn in 2021.
"North America is projected to reign the market owing to the government implementing strict workplace testing regulations as well as expansion strategies followed by players. Furthermore, the region's high adoption of technologically advanced solutions & favourable reimbursement scenarios has fuelled the market growth. New organ-on-a-chip platforms enable more precise and accurate perception of drug effects on the human body, and its advancements are also contributing to the growth of the North American drug screening market." asserts an FMI researcher.
Buy Now Report Here: https://www.futuremarketinsights.com/checkout/14265
Comparative View of Adjacent Drug Screening Market
| Attributes | Drug Screening Market | Drug Discovery Services Market | Drug Testing Market | |||
| CAGR(2022 - 2032) | 16% | 15% | 5% | |||
| Market Value(2026) | US$ 11 Bn | US$ 32 Bn | US$ 27.5 Bn | |||
| Growth Factor | Increasing use of alcohol and drug consumption and underlying risks is increasing law enforcement. | Increasing R&D spending in biopharmaceutical and pharmaceutical industry to upkeep adoption of drug discovery services. | Government mandates for monitoring and combating substance abuse to augment adoption. | |||
| Opportunity | Stringent regulation in North America to keep the attractive quotient of the region intact. | Offering skilled professionals in Asia Pacific market to provide opportunities. | Investment in consumables for the development of advanced products to offer lucrative opportunities. | |||
| Key Trends | Growing drug rehabilitation centers translate to increasing adoption of drug screening devices. | Companies offering drug discovery services are spending towards setting up new R&D facilities. | Demand for innovative testing solutions for opioid to remain high. | |||
Buy Now@ https://www.futuremarketinsights.com/checkout/14265
Competitive Landscape:
Some of the notable players in the drug screening market are Premier Biotech (US), Abbott Laboratories (US), Alfa Scientific Designs (US), OraSure Technologies (US), Shimadzu (Japan), Drägerwerk (Germany), LifeLock (US), Thermo Fisher Scientific (US), MPD Inc. (US), Omega Laboratories (US), Psychemedics (US), Roche (Switzerland), and Siemens Healthineers (Germany), Quest Diagnostics (US).
To capture larger market shares, key companies are pursuing various growth strategies such as mergers and acquisitions, geographic expansion, product invention leading to some significant recent developments in the drug screening market.
- Drager Safety Canada's Drager drug test 5000 drug testing device received government approval, making it the country's first roadside oral fluid drug testing device with active government support.
- Intelligent fingerprinting limited, based in the United Kingdom, has released the world's first portable fingerprint drug test to detect and analyze marijuana, opiates, and amphetamines. The newly launched device allows for sample collection and analysis in 10 minutes, speeding up the process.
Request Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14265
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Quadriplegia Treatment Market: According to the latest research by Future Market Insights, quadriplegia treatment market is expected to grow at a CAGR of 4.1% during the forecast period.
Neurology Digital Therapeutics Market: According to the recent research by FMI, the neurology digital therapeutics market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031.
Repositioning and Offloading Market: According to the latest research by Future Market Insights, the repositioning and offloading market is set to experience ~4% (CAGR) growth during the year 2021-2031.
Injectable Potassium Phosphate Market: According to the latest research by Future Market Insights, the injectable potassium phosphate market is set to experience ~8.6% (CAGR) growth during the year 2021-2031.
Histoplasmosis Treatment Market: Histoplasmosis Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031.
CRISPR Genomic Cure Market: According to the latest research by Future Market Insights, the CRISPR Genomic Cure market will undergo a steady growth during 2021-2031.
Malaria Ag Rapid Testing Market: According to the latest research by Future Market Insights, Malaria Ag rapid Testing Market is set to experience 5% growth during the year 2021-2031.
Human Osteoblasts Market: According to the latest research by Future Market Insights, Human osteoblasts market is set to witness a 7.1% growth during the year 2021-2031.
Fluid Transfer Solutions Market: According to the latest research by Future Market Insights, the Fluid transfer solutions market is set to witness a growth of 5% and 7% during 2021-2031.
Bioprocess Containers & Fluid Transfer Solutions Market: According to the latest research by Future Market Insights, the bioprocess containers & fluid transfer solutions market is set to witness a 14.7% growth during the year 2021-2031.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/drug-screening-market
Press Release Source: https://www.futuremarketinsights.com/press-release/drug-screening-market
